The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / As Population Ages, Rheumatologists Prepare to Treat Elderly Patients with More Comorbidities

As Population Ages, Rheumatologists Prepare to Treat Elderly Patients with More Comorbidities

November 1, 2012 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Resources for Geriatric Rheumatology

  • ACR 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip and Knee: www.rheumatology.org/practice/clinical/
    guidelines/PDFs/
    ACR_OA_Guidelines_FINAL.pdf
  • American Geriatrics Society: www.americangeriatrics.org
  • Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: www.americangeriatrics.org/files/documents/
    beers/2012BeersCriteria_JAGS.pdf
  • Health Literacy Consulting: Helen Osborne’s website featuring various articles and podcasts about better patient communication and education: http://healthliteracy.com and www.healthliteracyoutloud.com
  • Herpes Zoster (Shingles) Vaccine Guidelines for Immunosuppressed Patients: www.rheumatology.org/publications/hotline/
    2008_08_01_shingles.asp
  • Number of Older Americans: Contains a number of facts and figures on the elderly population growth in the United States: www.agingstats.gov/Main_Site/Data/
    2010_Documents/Population.aspx

With the first crop of baby boomers turning 65 last year—part of the so-called silver tsunami that will cause the elderly population to double by 2030—there’s no question that rheumatologists are going to be treating older patients more frequently.

You Might Also Like
  • ACR Increases Its Role in Educating Rheumatologists About Treating Geriatric Patients
  • How to Manage Pain & Treatment in Elderly Patients
  • Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients
Explore This Issue
November 2012
Also By This Author
  • Autoantibodies Against LINE-1 p40 May Be More Common in Patients with Active SLE

By 2050, the U.S. population over the age of 85 is expected to reach 19 million, compared with only 5.7 million in 2008, according to the U.S. Census Bureau.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Rheumatology patients in their late 70s, 80s, 90s, and 100s have some special considerations compared to the younger population.

“Older patients tend to have more comorbidities and resultant polypharmacy, making management issues for rheumatologic conditions more challenging,” says Una Makris, MD, assistant professor in the department of internal medicine in the division of rheumatic diseases at the University of Texas Southwestern Medical Center in Dallas.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

This means you’ll often find nonrheumatic comorbidities—for example, cardiovascular disease and diabetes—in addition to multiple rheumatological conditions, says Yuri Nakasato, MD, a rheumatologist at Sanford Health Systems and the University of North Dakota in Fargo. For example, a common scenario might be a patient with rheumatoid arthritis (RA), severe osteoarthritis (OA), and gout.

With individuals living longer, clinicians are now also observing the aging of rheumatic diseases, says Dr. Nakasato. This can include more sites of disease—for example, OA in the knees, hands, hips, and spine, Dr. Makris says.

“In the past, there was increased mortality. With that now decreasing, we’re seeing patients getting older,” Dr. Nakasato says. This adds another layer to the complexity of treatment.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

At the same time, clinicians are treating patients for conditions that are occurring for the first time in their older age, such as elderly onset RA, says Raymond Yung, MB, ChB, chief of the division of geriatric and palliative medicine in the department of internal medicine and codirector of the geriatrics center at the University of Michigan in Ann Arbor. Drs. Nakasato and Yung recently coedited a textbook called Geriatric Rheumatology (Springer, 2011).

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Crystal Arthritis, Guidelines, Osteoarthritis, Rheumatoid Arthritis Tagged With: antiinflammatory, drug, geriatric, Gout, HYDROXYCHLOROQUINE, Osteoarthritis, patient care, patient communication, Patients, Practice Management, Rheumatoid arthritis, Treatment, vaccineIssue: November 2012

You Might Also Like:
  • ACR Increases Its Role in Educating Rheumatologists About Treating Geriatric Patients
  • How to Manage Pain & Treatment in Elderly Patients
  • Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients
  • Treat to Target: Rheumatoid Arthritis in Pregnant Patients

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.